[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100609668":3},{"organization":4,"armGroups":7,"interventions":23,"overallOfficials":29,"centralContacts":34,"locations":40,"responsibleParty":58,"collaborators":60,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":28,"eligibilityCriteria":70,"healthyVolunteers":66,"sex":71,"minAge":72,"maxAge":28,"enrollmentInfo":73,"targetDuration":28,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":82,"overallStatus":43,"whyStopped":28,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"University of Oklahoma","OTHER",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"Open Pilot Study","EXPERIMENTAL","During the open pilot study, which will take place over a 3-month period, up to 15 patients will be enrolled to receive the C3PO intervention. At the conclusion of this period, exit interviews will be conducted to gather feedback on the implementation of the intervention. The primary objective of this phase is to assess the strengths and weaknesses of the intervention in order to inform potential improvements before advancing to the next phase of the study",[13],"Other: C3PO",{"label":15,"type":10,"description":16,"interventionNames":17},"C3PO Intervention","In Phase II of the study, patients will be randomized 1:1 by site and cancer type to either the C3PO intervention group or the usual care group. Those assigned to the C3PO arm will receive navigation services at SCC, along side collaborative care meetings (C3PO). These meetings, held without the patient present, will focus on discussing the patient's overall needs, such as potential adverse effects of cancer treatment, the impact of co-morbid conditions, etc,.",[13],{"label":19,"type":20,"description":21,"interventionNames":22},"Usual Care","ACTIVE_COMPARATOR","Patients randomized to the usual care group will receive navigation services only and will not participate in the C3PO intervention during the initial 6 months. However, after this 6-month period, they will become eligible to receive the C3PO intervention, following the same process as the initial intervention group.",[13],[24],{"type":6,"name":25,"description":26,"armGroupLabels":27,"otherNames":28},"C3PO","Participants assigned to C3PO will receive usual navigation services with a Native American Navigator (NAN) at the SCC but will begin having their clinical care and social needs discussed during monthly collaborative care meetings. For the Open Pilot, this will include all participants (no randomization or usual care group). The collaborative care coordinator will meet with the participant virtually or in-person before and after collaborative care meetings as they are available and as needs arise.",[15,9,19],null,[30],{"name":31,"affiliation":32,"role":33},"Amanda Janitz, Ph.D.","University of Oklahoma Stephenson Cancer Center","PRINCIPAL_INVESTIGATOR",[35],{"name":31,"role":36,"phone":37,"phoneExt":38,"email":39},"CONTACT","405-271-2229","48081","Amanda-Janitz@ou.edu",[41],{"facility":42,"status":43,"city":44,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"OU Health Stephenson Cancer Center","RECRUITING","Oklahoma City","Oklahoma","73117","United States","US",{"type":50,"coordinates":51},"Point",[52,53],-97.51643,35.46756,{"lat":53,"lon":52},[56],{"name":31,"role":36,"phone":28,"phoneExt":28,"email":57},"Amanda-Janitz@ouhsc.edu",{"type":59,"investigatorFullName":28,"investigatorTitle":28,"investigatorAffiliation":28,"oldNameTitle":28,"oldOrganization":28},"SPONSOR",[61],{"name":62,"class":63},"National Institute on Minority Health and Health Disparities (NIMHD)","NIH","100609668","program-in-oncology-for-tribal-health-systems-100609668",false,"NCT07217574","Program in Oncology for Tribal Health Systems.","Care Coordination and Communication Program in Oncology for Tribal Health Systems (C3PO)","Inclusion Criteria:\n\n* Participants must be at least 18 years of age, within eight weeks of newly diagnosed cancer confirmed by pathology\u002Fimaging, navigated through the NANP at SCC and have verbal fluency in English.\n\nExclusion Criteria:\n\n* Participants in the Phase 1 open pilot will not be eligible for the Phase 2 RCT.","ALL","18 Years",{"count":74,"type":75},187,"ESTIMATED","INTERVENTIONAL",[78],"NA","This clinical trial aims to develop and implement more navigation assistance programs tailored specifically for Native American cancer patients, addressing the current lack of available support. The goal is to improve communication barriers within the healthcare system by fostering a collaborative approach between the Stephenson Cancer Center (SCC) and tribally operated healthcare systems (ITU). Through this partnership, the trial seeks to enhance patient outcomes by providing culturally sensitive, coordinated care.",[81],"Patient Outcomes",[83,84],"American Indian (AI)","American Native (AN)","2026-06-08",{"date":87,"type":88},"2026-06-11","ACTUAL",{"date":90,"type":88},"2026-02-11",{"date":92,"type":75},"2031-03",{"name":5,"class":6},1]